Clinical Data and Medicus Middleware Announce Availability of Chameleon Middleware System for Medical Labs in U.S.
NEWTON, Mass.–(BUSINESS WIRE)–Clinical Data, Inc. (NASDAQ: CLDA) and Medicus Middleware, Inc. today announced the availability of the Chameleon™ Middleware System for medical laboratories in the United States. Chameleon is an exclusive product of Clinical Data Sales & Service, Inc. (CDSS) that allows laboratories to connect multiple analyzers to a single LIS/EMR interface. Chameleon includes a powerful, rule-based auto validation system that is designed to be simple for the user to manage. Rules can be added or changed at any time by simply having the user select parameters from a menu of choices. This enables the laboratory to increase result throughput, vastly improve operator efficiency, and decrease overall turnaround time.
Ronald J. Rossman, President of Medicus Middleware Systems, said, “Developed from the ground up as a middleware system, Chameleon is the next evolutionary step in laboratory data workflow management.”
Gus Gardner, President of CDSS, commented, “This agreement gives us a powerful, low-cost data management solution for our distribution partners and their customers in the physician office lab and small clinical lab testing markets. Chameleon allows lab data to become EMR information in a seamless, hands-off tool. This allows the lab to focus on best practices without the diversion of the typical technical and data challenges.”
Chameleon comes standard with six preprogrammed analyzer interfaces and an embedded LIS/EMR interface, a full QC management system, cumulative patient results storage, communication logging, automatic data traceability, CLIA compliant reports and a failsafe data buffering system designed to protect critical data transmissions from connection interruptions. Chameleon’s interface engine has built in real time communication diagnostics and can operate in several modes from fully automatic pass through of results to completely manual validation of all results. The Chameleon interface engine can communicate via serial or on a network using TCP allowing for maximum configuration flexibility.
About Medicus Middleware, Inc.
Medicus Middleware, Inc has been developing OEM data systems for the medical laboratory industry since 1996 and is located in Nashville Tennessee with a satellite office in Thibodaux Louisiana. Medicus Middleware currently has over 700 systems in the field in the U.S and Europe.
About Clinical Data, Inc.
Clinical Data, Inc., a worldwide leader in providing comprehensive molecular and pharmacogenomics services as well as genetic tests to improve patient care, is organized under three worldwide divisions segmented by service offerings and varying client constituents: PGxHealth™; Cogenics™; and Vital Diagnostics™. The Pharmacogenomics and Molecular Services™ division, Cogenics, consolidates operations of Genaissance Pharmaceuticals, Inc., Lark Technologies, Inc., Icoria, Inc., and Genome Express SA to provide a comprehensive range of molecular biology and pharmacogenomics services to pharmaceutical, biotech, academic, agricultural, and government clients. These services are offered in both research and regulated environments and have applications across the lifecycle of pharmaceutical product development including pharmacovigilance requirements post-launch. PGxHealth builds upon existing assets and know-how acquired from Genaissance Pharmaceuticals, Icoria, and Genome Express in the areas of genomics-based, genetic tests and therapeutic efficacy and safety biomarker development for drug utilization. PGxHealth develops, validates and commercializes novel Therapeutic Diagnostics™, in some instances in combination with new and existing therapeutics, to improve patient care. In addition, PGxHealth has a therapeutic drug candidate, vilazodone, currently in late stage clinical trials for the treatment of depression. Vital Diagnostics serves the clinical laboratory in the traditional in-vitro diagnostics market worldwide. With a focus on the physician’s office, hospital and small-to-medium sized laboratory segments and customers in approximately 100 countries, Vital Diagnostics has achieved a leading market share for instruments and reagents sold into moderately complex physicians’ office laboratories within the United States. Clinical Data is headquartered in Newton, Mass. with operations in Texas, Connecticut, North Carolina, Rhode Island, and California as well as internationally in the UK, France, the Netherlands, and Italy.
Internet Website: www.clda.com
